Why IMU is a multi multi bagger, page-23925

Let me give you this potential scenario and you can decide if it makes sense.

IMU doing trials and LC have been kept updated on the latest. In her updates, she knows that the trials are going very well. Told potentially some patients have achieve complete responses but yet to be independently confirmed.

Then she is asked, 'why is the share price so low'. She responded with 'I don't know'.

Don't you agree in such a scenario, her response of 'I don't know' makes sense?

In any case, only time will tell what is what. I am betting the next round of data released would be truly great. It would also help explains why the company is seemingly nonchalant about the current share price situation. And if the data released is less than impressive, well, that is the gamble we are all knowingly taking. After all, investing in a research biotech is always known to be highly speculative. Great risk/great reward.

Good luck.